BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 22138101)

  • 1. Prognostic value of platelet count in diffuse large B-cell lymphoma.
    Chen LP; Lin SJ; Yu MS
    Clin Lymphoma Myeloma Leuk; 2012 Feb; 12(1):32-7. PubMed ID: 22138101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin.
    Tisi MC; Bozzoli V; Giachelia M; Massini G; Ricerca BM; Maiolo E; D'Alo' F; Larocca LM; Piciocchi A; Tjalsma H; Swinkels DW; Voso MT; Leone G; Hohaus S
    Leuk Lymphoma; 2014 Feb; 55(2):270-5. PubMed ID: 23647063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI.
    Ruppert AS; Dixon JG; Salles G; Wall A; Cunningham D; Poeschel V; Haioun C; Tilly H; Ghesquieres H; Ziepert M; Flament J; Flowers C; Shi Q; Schmitz N
    Blood; 2020 Jun; 135(23):2041-2048. PubMed ID: 32232482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of inflammation in lymphoma.
    Carbone A; Tripodo C; Carlo-Stella C; Santoro A; Gloghini A
    Adv Exp Med Biol; 2014; 816():315-33. PubMed ID: 24818728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Diffuse Large B-cell Lymphoma of the Colon Presenting as Idiopathic Thrombocytopenia: A Case Report.
    Ravilla J; Heis F; Srinivas Yarrarapu SN; Li J; Taj S; Sanekommu H; Tayyeb M; Doantrang D; Kruger A
    J Community Hosp Intern Med Perspect; 2024; 14(1):75-79. PubMed ID: 38482079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin-platelet index as a prognostic factor in patients with peripheral T-cell lymphoma.
    Yagi Y; Kanemasa Y; Sasaki Y; Okumura S; Watanabe T; Ishimine K; Hayashi Y; Mino M; Ohigashi A; Morita Y; Tamura T; Nakamura S; Okuya T; Shimoyama T
    EJHaem; 2023 Aug; 4(3):656-666. PubMed ID: 37601871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of platelet-to-albumin ratio as a clinical predictor for diffuse large B-cell lymphoma.
    Wang J; Li L; Yu F; Zhang J; Mao L; Chen B; Hu X; Zhou H; Xie W; Tong H; Jin J
    Front Oncol; 2023; 13():1138284. PubMed ID: 37361573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of PD-L1 and YWHAZ in Patients with Diffuse Large B Cell Lymphoma: A Possible Association with the Prognosis of Lymphoma.
    Yan S; Shang Q; Fan Z; Yang Y; Liu Y; Gao H; Chen K; Liang F; Li X; Zhang Q; Yan H
    J Immunol Res; 2022; 2022():5633096. PubMed ID: 36213322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Marrow Infiltration Is a Distinctive Risk Factor for Rituximab Infusion-Related Reactions in CD20-Positive B-Cell Non-Hodgkin Lymphoma.
    Ohata S; Takenaka K; Sugiyama D; Sugimoto T
    Adv Hematol; 2022; 2022():3688727. PubMed ID: 35189630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure.
    Gile JJ; Lopez CL; Ruan GJ; Hathcock MA; Abeykoon JP; Heimgartner JR; Baumann NA; McMahon MM; Micallef IN; Johnston PB; Bisneto JCV; Porrata LF; Paludo J; Ansell SM; Hogan WJ; Witzig TE
    Blood Cancer J; 2021 Mar; 11(3):65. PubMed ID: 33771971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of Chronic Immune Thrombocytopenia Purpura after Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma.
    Kumar PA; Wazir A; Pu JJ
    J Med Cases; 2021 Jan; 12(1):37-40. PubMed ID: 33391580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Rg3 for Chemotherapy-Induced Myelosuppression: A Meta-Analysis and Systematic Review.
    Pan L; Zhang T; Cao H; Sun H; Liu G
    Front Pharmacol; 2020; 11():649. PubMed ID: 32477128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Value of Blood-Based Biomarkers in Patients With Testicular Diffuse Large B-Cell Lymphoma.
    Yang J; Guo X; Hao J; Dong Y; Zhang T; Ma X
    Front Oncol; 2019; 9():1392. PubMed ID: 31921649
    [No Abstract]   [Full Text] [Related]  

  • 14. Red blood cell distribution width and platelet counts are independent prognostic factors and improve the predictive ability of IPI score in diffuse large B-cell lymphoma patients.
    Li M; Xia H; Zheng H; Li Y; Liu J; Hu L; Li J; Ding Y; Pu L; Gui Q; Zheng Y; Zhai Z; Xiong S
    BMC Cancer; 2019 Nov; 19(1):1084. PubMed ID: 31711453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and prognostic factors of primary bone marrow lymphoma.
    Wang G; Chang Y; Wu X; Li X; Li L; Zhang L; Fu X; Sun Z; Zhang X; Zhang M
    Cancer Manag Res; 2019; 11():2553-2563. PubMed ID: 31015766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified MIPI-B prognostic stratification method can predict the outcome well-retrospective analysis of clinical characteristics and management of newly-diagnosed mantle cell lymphoma patients from China.
    He JS; Chen X; Wei GQ; Sun J; Zheng WY; Shi JM; Wu WJ; Zhao Y; Zheng GF; Huang H; Cai Z
    Medicine (Baltimore); 2019 Jan; 98(1):e13741. PubMed ID: 30608386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia Associated with Worse Outcome in Diffuse Large B-Cell Lymphoma Patients: A Single-Center Retrospective Study.
    Matsumoto K; Fujisawa S; Ando T; Koyama M; Koyama S; Ishii Y; Numata A; Yamamoto W; Motohashi K; Hagihara M; Nakajima H
    Turk J Haematol; 2018 Aug; 35(3):181-184. PubMed ID: 29589833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic effect of peripheral blood cell counts in advanced diffuse large B-cell lymphoma treated with R-CHOP-like chemotherapy: A single institution analysis.
    Yamauchi T; Tasaki T; Tai K; Ikegaya S; Takagi K; Negoro E; Kishi S; Yoshida A; Iwasaki H; Ueda T
    Oncol Lett; 2015 Feb; 9(2):851-856. PubMed ID: 25621059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy.
    Hong J; Woo HS; Kim H; Ahn HK; Sym SJ; Park J; Ahn JY; Cho EK; Shin DB; Lee JH
    Cancer Sci; 2014 Dec; 105(12):1569-75. PubMed ID: 25263825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of chemotherapy-induced hematological toxicity in metastatic colorectal cancer patients.
    Rambach L; Bertaut A; Vincent J; Lorgis V; Ladoire S; Ghiringhelli F
    World J Gastroenterol; 2014 Feb; 20(6):1565-73. PubMed ID: 24587632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.